46. Malignant rheumatoid arthritis Clinical trials / Disease details
Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR-IPR-15007415 | 2015-11-20 | 2015-11-19 | Study of Sinomenine Hydrochloride in the treatment of rheumatoid arthritis | Study of Sinomenine Hydrochloride in the treatment of rheumatoid arthritis | Rheumatoid arthritis | treatment group:sinomenine hydrochloride combined with MTX;controlled group:LEF combined with MTX; | Guangdong Provincial Hospital of Chinese Medicine | NULL | Recruiting | Both | treatment group:25;controlled group:25; | China |